Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis
Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Jun 21, 2022
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is looking at how effective shiatsu, a type of massage therapy, can be in reducing fatigue for patients with axial spondyloarthritis (axSpA), a type of inflammatory arthritis that mainly affects the spine. Fatigue is a common and challenging symptom for people with this condition, and currently, there are no specific treatments for it. Shiatsu involves applying gentle pressure to various points on the body to help improve overall well-being and energy flow.
To participate in this study, you need to be between 18 and 70 years old and have been diagnosed with spondyloarthritis. You should also be experiencing a certain level of fatigue. However, if you have any skin infections, have had shiatsu treatment before, or are pregnant, you won't be eligible. Participants will receive shiatsu treatments and will be monitored to see how these sessions affect their fatigue levels. This trial aims to provide valuable insights into how shiatsu might help improve the quality of life for those dealing with the challenges of spondyloarthritis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patients with spondyloarthritis meeting the ASAS criteria and followed in the rheumatology department of the Orléans Regional Hospital Center.
- • Men and women aged 18 to 70
- • Patients with digital or visual analog rating scale ≥ 3 on the 1st question of the BASDAI
- Exclusion Criteria:
- • Patient with a pathology that contraindicates the practice of shiatsu (evolving infectious skin pathology that would make shiatsu treatment difficult)
- • Previous shiatsu treatment
- • Inability to attend appointments for the duration of the study
- • Pregnant or breastfeeding woman
- • Refusal to participate in the study or to sign the consent
- • Patients not affiliated or not beneficiaries of a social security scheme
- • Person under guardianship or curatorship
- • Patient with an uncontrolled epileptic or psychotic condition which, in the opinion of the investigator, would interfere with the smooth running of the study
About Centre Hospitalier Régional D'orléans
The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orleans, , France
Patients applied
Trial Officials
Eric LESPESSAILLES, PH
Principal Investigator
CHR d'Orléans
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials